SecBot SecBot
DEFA14A ·Filed Apr 29, 2026

CMPX

Compass Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago SEC0001140361-26-017650
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for definitive proxy materials or subsequent filings that may reveal the nature of the proxy solicitation. The dissident-proxy amplifiers suggest heightened activist risk, but no concrete demands or financial data are available yet.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
CMPX ▲ +23.95% at T+60d
NEUTRAL call +23.95% · α vs SPY +19.84% · entry $1.67 → $2.07
Entry = T+0 close
Apr 29, 2026
via day close
T+1d
+5.99%
call +5.99% · α +4.96%
$1.77
settled 6mo ago
T+5d
+16.77%
call +16.77% · α +13.66%
$1.95
settled 6mo ago
T+20d
+35.93%
call +35.93% · α +30.47%
$2.27
settled 5mo ago
T+60d
+23.95%
call +23.95% · α +19.84%
$2.07
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Compass Therapeutics filed a DEFA14A (additional definitive proxy soliciting materials) on April 29, 2026. The filing content is unavailable, but the presence of dissident-proxy cross-filing amplifiers suggests a potential activist or proxy contest context. Without specific details, the impact remains uncertain.

Key Facts

  • Filed DEFA14A on 2026-04-29
  • Market cap: $331M
  • Amplifiers indicate dissident-proxy context
  • Document content unavailable

Financial Impact

Not determinable from filing metadata alone

Risk Factors

  • Potential activist intervention or board challenge
  • Uncertainty due to lack of filing content

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-017650
Document: 0001140361-26-017650-index-headers.html0001140361-26-017650
Document: 0001140361-26-017650-index.html0001140361-26-017650
Document: 0001140361-26-017650.txt0001140361-26-017650
15 reports for CMPX
Performance horizon
80% Hit rate @ T+20 8 of 10 directional calls Went positive at some point 10 of 11 best @ T+20▲ +32.82%Sep 22, 2026
Filters
Rows
Reports for CMPX — sortable, filterable
TypeNow
Oct 24, 2026
3d ago
Press Release
BULLISH ★ 7/10
$0.7472awaiting T+20—$0.7470 (−0.03%)
Sep 22, 2026
5w ago
8-K
BEARISH ★ 7/10
$1.24 $0.8330▲ +32.82%▲ +32.26%$0.7470 (+39.76%)
Aug 21, 2026
9w ago
Institutional Cluster
BULLISH ★ 7/10
$2.40 $1.90▼ −20.83%▼ −20.55%$0.7470 (−68.88%)
Aug 6, 2026
11w ago
8-K
BULLISH ★ 7/10
$1.99 $2.37▲ +19.10%▲ +18.50%$0.7470 (−62.46%)
Aug 6, 2026
11w ago
Press Release
BULLISH ★ 7/10
$1.99 $2.37▲ +19.10%▲ +18.50%$0.7470 (−62.46%)
Jul 17, 2026
14w ago
Press Release
BULLISH ★ 6/10
$2.05 $2.25▲ +9.76%▲ +5.31%$0.7470 (−63.56%)
Jul 1, 2026
16w ago
8-K
BULLISH ★ 7/10
$2.27 $1.94▼ −14.54%▼ −14.12%$0.7470 (−67.09%)
Jun 11, 2026
19w ago
Institutional Cluster
MIXED ★ 4/10
$2.03 $2.33▲ +14.78%▲ +13.00%$0.7470 (−63.20%)
May 21, 2026
22w ago
Press Release
BULLISH ★ 7/10
$2.07 $2.09▲ +0.72%▲ +2.14%$0.7470 (−63.91%)
May 5, 2026
25w ago
8-K
BULLISH ★ 7/10
$1.95 $2.08▲ +6.67%▲ +1.71%$0.7470 (−61.69%)
Showing 10 of 15

US Market Status

Market Closed — Opens Thu (11h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026